Privacy Policy
Signals Blog

Contributors

Categories

Gene Therapy To Treat HIV In Clinical Trial

John Farrell is a science and technology blogger for Forbes online. John was invited to cover proceedings at the 2015 Till & McCulloch Meetings and this is his second report. This blog also appears on Forbes and is reprinted here with permission. One of the more...

An interview with bioengineering pioneer Kevin Healy

In the fourth in her series on “What drives research in the field of biomaterials?” blogger Hamideh Emrani interviews Professor Kevin E. Healy at the University of California, Berkeley. You can catch up on Hamideh’s earlier interviews here. I met Professor Kevin Healy...

Cell Therapy Deal Review: November

Welcome to your Cell Therapy Deal Review for the month of November. Astellas failed to achieve the majority share it needed to push through a takeover of Ocata Therapeutics valued at $379 million. ImmunoCellular Therapeutics announced a research agreement with MD...

ISCT webinar: Reimbursement re-cap

For those of you that missed ISCT’s recent webinar on manufacturing, needle-to-needle logistics and reimbursement, below is a brief re-cap of the key points on the reimbursement section that I provided. The presentation, including audio, should be available free on...